DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

4.68 0.06 (1.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

THLD $4.68 1.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.58
Previous Close $4.62
Daily Range $4.56 - $4.75
52-Week Range $3.51 - $5.93
Market Cap $277.8M
P/E Ratio -13.20
Dividend (Yield) $0.00 (0.0%)
Volume 664,199
Average Daily Volume 775,077
Current FY EPS -$0.44

Sector

Healthcare

Industry

Drugs

THRESHOLD PHARMACEUTICALS, INC. (THLD) Description

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. Website: http://www.thresholdpharm.com/

News & Commentary Rss Feed

These 7 States Have the Highest Rates of Pancreatic Cancer

Pancreatic cancer is arguably the most lethal form of the disease. Find out which seven states this disease occurs in most often, as well as what new pathways are being tested to treat this terrible disease.

Apple Unveils Watch, Larger iPhones; Francesca's Shares Drop After Downbeat Results

Apple Unveils Watch, Larger iPhones; Francesca's Shares Drop After Downbeat Results

Threshold Pharmaceuticals, Inc. Shares Jump Amid H.C. Wainwright Initiation

Clinical Trial Results To Watch

Biotech Stock Mailbag: Threshold, Galena, CytRx

5 Stocks Ready for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Threshold Announces Initiation Of Dosing With TH-302/Bortezomib In Final Stage Of Ongoing Phase 1/2

Threshold Announces Initiation Of Dosing With TH-302/Bortezomib In Final Stage Of Ongoing Phase 1/2 Trial Of Patients With Relapsed/Refractory Multiple Myeloma

Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer

See More THLD News...

THLD's Top Competitors

THLD $4.68 (1.30%)
Current stock: THLD
AMGN $140.71 (0.99%)
Current stock: AMGN
GILD $103.84 (-0.88%)
Current stock: GILD
BIIB $327.58 (0.21%)
Current stock: BIIB